Advanced Therapies for Ulcerative Colitis: A Critical Look at Comparative Data

Download All
These downloadable slides include expert faculty discussion on the comparable efficacy and risks of specific biologic therapies for treating moderate to severe UC that include TNF inhibitors and non–TNF inhibitor biologics, allowing you to use these comparisons to make optimal treatment decisions for your patients.
Gary Lichtenstein Headshot
Gary R. Lichtenstein, MD
Uma Mahadevan, MD

Downloadable Slideset

Explore the comparable efficacy, risks, and real-world data on specific biologic and small molecules therapies for treating moderate to severe ulcerative colitis.

Gary Lichtenstein Headshot Gary R. Lichtenstein, MD Uma Mahadevan, MD Released: January 24, 2020
Provided by the American Gastroenterological Association

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue